What is the current Autoimmune Disorder Drug Delivery Devices market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Autoimmune Disorder Drug Delivery Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Autoimmune Disorder Drug Delivery Devices market?

Increasing prevalence of autoimmune disorders and advancements in drug delivery technologies drive the market.

What are the major challenges facing the Autoimmune Disorder Drug Delivery Devices market?

High development costs and stringent regulatory requirements pose significant challenges.

Which regions are leading the Autoimmune Disorder Drug Delivery Devices market?

North America and Europe are the leading regions due to high healthcare expenditure.

What are the future opportunities in the Autoimmune Disorder Drug Delivery Devices market?

Emerging markets and innovative technologies offer significant future outlook and growth prospects.

How is technology impacting the Autoimmune Disorder Drug Delivery Devices market?

Advances in nanotechnology and biodegradable materials are improving drug delivery efficacy and safety.

What is the current regulatory landscape for the Autoimmune Disorder Drug Delivery Devices market?

Regulatory bodies such as FDA and EMA are implementing strict guidelines for device approval and commercialization.

What is the expected future outlook for the Autoimmune Disorder Drug Delivery Devices market?

The market is expected to witness significant growth due to increasing demand for targeted and efficient drug delivery systems.

Autoimmune Disorder Drug Delivery Devices Growth Drivers & Forecast Analysis 2033

Autoimmune Disorder Drug Delivery Devices by Application (Hospital, Clinic), by Types (Pen Injectors, Auto-Injectors, Pre-filled Syringes, Vials), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Autoimmune Disorder Drug Delivery Devices Market Size | CAGR 2019 Forecast 2033

Autoimmune Disorder Drug Delivery Devices Growth Drivers & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Autoimmune Disorder Drug Delivery Devices Market Overview

The Autoimmune Disorder Drug Delivery Devices market refers to the industry that develops and manufactures devices for delivering drugs to treat autoimmune disorders, which are conditions where the body's immune system mistakenly attacks its own cells. The Autoimmune Disorder Drug Delivery Devices market size is estimated to be around $13.4 billion in 2025, with a growth outlook that is expected to be driven by the increasing prevalence of autoimmune disorders and the need for more effective and convenient treatment options. The market forecast suggests that the industry will experience a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033, driven by industry expansion into new technologies and markets. The scope of the market includes devices such as injectors, pumps, and patches, which are used to deliver drugs such as biologics and small molecules to treat conditions such as rheumatoid arthritis, multiple sclerosis, and diabetes.

Loading chart…

The Autoimmune Disorder Drug Delivery Devices market is driven by several key forces, including technology shifts towards more advanced and convenient devices, regulations that prioritize patient safety and efficacy, and consumer behavior that demands more personalized and effective treatment options. The largest region in the market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare spending and a growing middle class. Overall, the Autoimmune Disorder Drug Delivery Devices market is expected to experience significant growth and industry expansion over the forecast period, driven by the increasing need for effective and convenient treatment options for autoimmune disorders.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Gerresheimer; Schott; J.O.Pharma; Nipro; Roselabs; Fresenius Kabi; Baxter; West Pharma; Terumo; Taisei Kako; MedXL; Cardinal Health; Guerbet; Catalent; Weigao; Stevanato; Rovi CM; Zibo Minkang; Vetter Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Autoimmune Disorder Drug Delivery Devices market is witnessing significant growth, driven by increasing demand for effective treatment options. This section provides an overview of the market dynamics, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Advances in technology have led to the development of innovative Autoimmune Disorder Drug Delivery Devices, enhancing patient outcomes and driving market growth. The Autoimmune Disorder Drug Delivery Devices market size is expected to expand due to the increasing adoption of these devices.

The rising prevalence of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis, is fueling the demand for effective treatment options, thereby contributing to the growth forecast of the Autoimmune Disorder Drug Delivery Devices market.

Restraints2 items

High development costs and stringent regulatory requirements are major restraints in the Autoimmune Disorder Drug Delivery Devices market. These factors can limit the entry of new players and hinder the growth of existing ones.

The complexity of autoimmune disorders and the need for personalized treatment approaches can make it challenging to develop effective Autoimmune Disorder Drug Delivery Devices, thereby restraining market growth.

Opportunities2 items

The increasing focus on patient-centric care and the growing demand for home-based treatment options are creating opportunities for the development of innovative Autoimmune Disorder Drug Delivery Devices. This shift is expected to drive the growth forecast of the market.

Collaborations between pharmaceutical companies and device manufacturers can lead to the development of more effective Autoimmune Disorder Drug Delivery Devices, addressing the complex needs of patients with autoimmune disorders and expanding the Autoimmune Disorder Drug Delivery Devices market size.

Challenges2 items

The Autoimmune Disorder Drug Delivery Devices market faces challenges related to pricing pressures and competition from existing treatment options. Manufacturers must balance the cost of development with the need to offer affordable solutions to patients.

Ensuring the supply chain resilience and managing macroeconomic factors, such as fluctuations in raw material costs, are critical challenges that companies in the Autoimmune Disorder Drug Delivery Devices market must address to maintain their competitive edge.

Market Segmentation

Loading chart…

The Application segment of the Autoimmune Disorder Drug Delivery Devices market refers to the various uses of these devices in treating different autoimmune disorders. This segment is crucial in understanding the Autoimmune Disorder Drug Delivery Devices segmentation as it highlights the specific areas where these devices are most effective. The application segment includes subtypes such as rheumatoid arthritis, multiple sclerosis, and type 1 diabetes, among others. Each subtype has its unique requirements for drug delivery, contributing to the overall market size.

The Types segment of the Autoimmune Disorder Drug Delivery Devices market encompasses the different kinds of devices used to deliver drugs for treating autoimmune disorders. This segment is vital in market taxonomy as it categorizes devices based on their characteristics, such as injectable devices, inhalable devices, and transdermal devices. Each type of device has its advantages and limitations, influencing the overall market size. Understanding the types of devices available helps in assessing the market's potential for growth and innovation.

Autoimmune Disorder Drug Delivery Devices Segmentation Breakdown8 items

Application

Hospital

Clinic

Types

Pen Injectors

Auto-Injectors

Pre-filled Syringes

Vials

Regional Insights

Loading chart…

The Autoimmune Disorder Drug Delivery Devices market growth is anticipated to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the market, driven by key factors such as high adoption rates, favorable policies, and significant investments in research and development. The region's mature ecosystem and well-established infrastructure also contribute to its dominance.

In contrast, the Asia Pacific region is expected to be the fastest-growing, driven by increasing demographics, growing infrastructure, and rising ecosystem maturity. Europe, with a share of around 30%, is driven by factors such as high adoption rates, favorable policies, and significant investments in research and development. Latin America and Middle East & Africa, with shares of around 15% and 15% respectively, are driven by growing demographics, improving infrastructure, and increasing ecosystem maturity.

Regional Drivers5 items

North America: high adoption rates, favorable policies, significant investments

Europe: high adoption rates, favorable policies, significant investments

Asia Pacific: increasing demographics, growing infrastructure, rising ecosystem maturity

Latin America: growing demographics, improving infrastructure, increasing ecosystem maturity

Middle East & Africa: growing demographics, improving infrastructure, increasing ecosystem maturity

Competitive Landscape

The Autoimmune Disorder Drug Delivery Devices market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The competitive landscape is shaped by key levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. As a result, the Autoimmune Disorder Drug Delivery Devices competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and service models.

Companies in this market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To mitigate these risks, companies focus on competitive differentiation through technology, service models, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

BD: regional expansion

Gerresheimer: innovation pipeline

Schott: premium pricing

J.O.Pharma: OEM tie-ups

Nipro: local manufacturing

Rosed Labs: vertical integration

Key Autoimmune Disorder Drug Delivery Devices Companies20 items

Gerresheimer

Schott

J.O.Pharma

Nipro

Roselabs

Fresenius Kabi

Baxter

West Pharma

Terumo

Taisei Kako

MedXL

Cardinal Health

Guerbet

Catalent

Weigao

Stevanato

Rovi CM

Zibo Minkang

Vetter Pharma

Market Ecosystem

The Autoimmune Disorder Drug Delivery Devices ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and manufacturers, to downstream channels and end users. This ecosystem is characterized by a sequential value chain, where raw materials and components are transformed into finished products, which are then distributed and delivered to patients. The creation and capture of value within this ecosystem is influenced by the interactions and relationships between these participants.

Raw material/component suppliers — providing essential materials

OEMs / manufacturers — designing and producing devices

Technology providers — developing innovative delivery systems

System integrators / EPCs — integrating devices with other systems

Distributors / channel partners — delivering devices to healthcare providers

Regulators/standards bodies — establishing safety and efficacy standards

End users / buyers — patients and healthcare providers utilizing devices

The flow of value within the Autoimmune Disorder Drug Delivery Devices ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact adoption rates. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's functioning. Additionally, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. A thorough value chain analysis is necessary to understand these dynamics and identify opportunities for innovation and growth. The ecosystem's characteristics may differ by region, with varying regulatory frameworks, healthcare systems, and patient needs shaping the market.

Recent Industry Insights

The Autoimmune Disorder Drug Delivery Devices industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships between pharmaceutical companies and medical device manufacturers have been forged, aiming to enhance drug delivery systems for autoimmune disorders. Recently, there have been several mergers & acquisitions, such as the acquisition of a leading biotech firm by a prominent pharmaceutical company, which has expanded its portfolio of autoimmune disorder treatments.

Furthermore, the industry has seen the launch of innovative product/technology solutions, including wearable devices and implantable drug delivery systems. Regulatory changes, such as the updated guidelines for the approval of drug delivery devices, have also impacted the industry. A shift in consumer or enterprise trends towards personalized medicine has driven the demand for advanced drug delivery devices. Additionally, several companies have secured funding rounds or expansions to support the development of novel autoimmune disorder treatments, shaping the future of the Autoimmune Disorder Drug Delivery Devices industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Autoimmune Disorder Drug Delivery Devices market outlook. The market exhibits high attractiveness due to the increasing prevalence of autoimmune disorders and the growing need for efficient drug delivery systems. The competitive intensity is moderate, with key players focusing on innovative solutions to gain a market share. The long-term outlook is promising, driven by advancements in technology and rising demand for personalized medicine.

The innovation landscape is dynamic, with companies investing in research and development to improve device efficacy and patient outcomes. The demand–supply balance is stable, with manufacturers catering to the growing demand for autoimmune disorder treatments. However, key risk factors include regulatory challenges and patent expirations, which may impact market growth. Overall, the Autoimmune Disorder Drug Delivery Devices market is poised for growth, driven by emerging trends and technologies.

12 items

1. Executive Summary

2. Autoimmune Disorder Drug Delivery Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Autoimmune Disorder Drug Delivery Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Autoimmune Disorder Drug Delivery Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Autoimmune Disorder Drug Delivery Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Autoimmune Disorder Drug Delivery Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Autoimmune Disorder Drug Delivery Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Autoimmune Disorder Drug Delivery Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Autoimmune Disorder Drug Delivery Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Autoimmune Disorder Drug Delivery Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Autoimmune Disorder Drug Delivery Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Autoimmune Disorder Drug Delivery Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Autoimmune Disorder Drug Delivery Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Autoimmune Disorder Drug Delivery Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Autoimmune Disorder Drug Delivery Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Autoimmune Disorder Drug Delivery Devices Market Competition by Key Manufacturers

9.1. Global Autoimmune Disorder Drug Delivery Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Autoimmune Disorder Drug Delivery Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Gerresheimer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Schott

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. J.O.Pharma

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Nipro

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Roselabs

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Fresenius Kabi

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Baxter

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. West Pharma

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Terumo

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Taisei Kako

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. MedXL

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Cardinal Health

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Guerbet

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Catalent

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Weigao

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Stevanato

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Rovi CM

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Zibo Minkang

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Vetter Pharma

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Autoimmune Disorder Drug Delivery Devices Market

Figure 4: Global Autoimmune Disorder Drug Delivery Devices Market: Drivers

Figure 5: Global Autoimmune Disorder Drug Delivery Devices Market: Challenges

Figure 6: Global Autoimmune Disorder Drug Delivery Devices Market: Trends

Figure 7: Global Autoimmune Disorder Drug Delivery Devices Market: Opportunity

Figure 8: Global Autoimmune Disorder Drug Delivery Devices Market: Restraint

Figure 9: Global Autoimmune Disorder Drug Delivery Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Autoimmune Disorder Drug Delivery Devices Market Value (USD Million) By Region

Figure 19: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Autoimmune Disorder Drug Delivery Devices Market Value (USD Million) By Region

Figure 27: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By: Regions (2032)

Figure 28: Global Autoimmune Disorder Drug Delivery Devices Market Volume (K) By Region

Figure 29: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Autoimmune Disorder Drug Delivery Devices Market Value (USD Million) By Region

Figure 37: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By: Regions (2032)

Figure 38: Global Autoimmune Disorder Drug Delivery Devices Market Volume (K) By Region

Figure 39: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

135 items

Table 1: Market Segmentation Analysis

Table 2: Global Autoimmune Disorder Drug Delivery Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Autoimmune Disorder Drug Delivery Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Autoimmune Disorder Drug Delivery Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Autoimmune Disorder Drug Delivery Devices Market Value (USD Million) By Region

Table 14: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Autoimmune Disorder Drug Delivery Devices Market Volume (K) By Region

Table 31: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Autoimmune Disorder Drug Delivery Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Autoimmune Disorder Drug Delivery Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Autoimmune Disorder Drug Delivery Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Gerresheimer Basic Information And Sales Area

Table 54: Gerresheimer. Products Portfolio

Table 55: Schott Basic Information And Sales Area

Table 56: Schott. Products Portfolio

Table 57: J.O.Pharma Basic Information And Sales Area

Table 58: J.O.Pharma. Products Portfolio

Table 59: Nipro Basic Information And Sales Area

Table 60: Nipro. Products Portfolio

Table 61: Roselabs Basic Information And Sales Area

Table 62: Roselabs. Products Portfolio

Table 63: Fresenius Kabi Basic Information And Sales Area

Table 64: Fresenius Kabi. Products Portfolio

Table 65: Baxter Basic Information And Sales Area

Table 66: Baxter. Products Portfolio

Table 67: West Pharma Basic Information And Sales Area

Table 68: West Pharma. Products Portfolio

Table 69: Terumo Basic Information And Sales Area

Table 70: Terumo. Products Portfolio

Table 71: Taisei Kako Basic Information And Sales Area

Table 72: Taisei Kako. Products Portfolio

Table 73: MedXL Basic Information And Sales Area

Table 74: MedXL. Products Portfolio

Table 75: Cardinal Health Basic Information And Sales Area

Table 76: Cardinal Health. Products Portfolio

Table 77: Guerbet Basic Information And Sales Area

Table 78: Guerbet. Products Portfolio

Table 79: Catalent Basic Information And Sales Area

Table 80: Catalent. Products Portfolio

Table 81: Weigao Basic Information And Sales Area

Table 82: Weigao. Products Portfolio

Table 83: Stevanato Basic Information And Sales Area

Table 84: Stevanato. Products Portfolio

Table 85: Rovi CM Basic Information And Sales Area

Table 86: Rovi CM. Products Portfolio

Table 87: Zibo Minkang Basic Information And Sales Area

Table 88: Zibo Minkang. Products Portfolio

Table 89: Vetter Pharma Basic Information And Sales Area

Table 90: Vetter Pharma. Products Portfolio

Table 91: Global Market Value (USD Million) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Value (USD Million) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Market Volume (K) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Market Volume (K) (2025-2032) By Types

Table 98: Global Market Share (%) By Types (2032)

Table 99: Global Autoimmune Disorder Drug Delivery Devices Market Value (USD Million) By Region

Table 100: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By Region (2025-2032)

Table 101: North America Market Value (USD Million) (2025-2032) By Country

Table 102: North America Market Value (USD Million) (2025-2032) By Application

Table 103: North America Market Value (USD Million) (2025-2032) By Types

Table 104: Europe Market Value (USD Million) (2025-2032) By Country

Table 105: Europe Market Value (USD Million) (2025-2032) By Application

Table 106: Europe Market Value (USD Million) (2025-2032) By Types

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 110: South America Market Value (USD Million) (2025-2032) By Country

Table 111: South America Market Value (USD Million) (2025-2032) By Application

Table 112: South America Market Value (USD Million) (2025-2032) By Types

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 116: Global Autoimmune Disorder Drug Delivery Devices Market Volume (K) By Region

Table 117: Global Autoimmune Disorder Drug Delivery Devices Market Share (%) By Region (2025-2032)

Table 118: North America Market Volume (K) (2025-2032) By Country

Table 119: North America Market Volume (K) (2025-2032) By Application

Table 120: North America Market Volume (K) (2025-2032) By Types

Table 121: Europe Market Volume (K) (2025-2032) By Country

Table 122: Europe Market Volume (K) (2025-2032) By Application

Table 123: Europe Market Volume (K) (2025-2032) By Types

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 125: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 127: South America Market Volume (K) (2025-2032) By Country

Table 128: South America Market Volume (K) (2025-2032) By Application

Table 129: South America Market Volume (K) (2025-2032) By Types

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 131: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 133: Research Programs/Design For This Report

Table 134: Key Data Information From Secondary Sources

Table 135: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Autoimmune Disorder Drug Delivery Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Gerresheimer; Schott; J.O.Pharma; Nipro; Roselabs; Fresenius Kabi; Baxter; West Pharma; Terumo; Taisei Kako; MedXL; Cardinal Health; Guerbet; Catalent; Weigao; Stevanato; Rovi CM; Zibo Minkang; Vetter Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options